These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11383585)

  • 1. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.
    Yamaguchi T; Ihara K; Matsumoto T; Tsutsumi Y; Nomura A; Ohga S; Hara T
    Inflamm Bowel Dis; 2001 May; 7(2):128-32. PubMed ID: 11383585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.
    Visser G; Rake JP; Labrune P; Leonard JV; Moses S; Ullrich K; Wendel U; Groenier KH; Smit GP
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S83-7. PubMed ID: 12373578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function.
    Alsultan A; Sokol RJ; Lovell MA; Thurman G; Ambruso DR
    Pediatr Blood Cancer; 2010 Dec; 55(7):1410-3. PubMed ID: 20830779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease-like colitis in a young Turkish child with glycogen storage disease type 1b and elevated platelet count.
    Saltik-Temizel IN; Koçak N; Ozen H; Yüce A; Gürakan F; Demir H
    Turk J Pediatr; 2005; 47(2):180-2. PubMed ID: 16052862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the diagnosis, treatment, and follow-up of a group of Turkish pediatric glycogen storage disease type 1b patients with varying clinical presentations and a novel mutation.
    Küçükçongar Yavaş A; Engin Erdal A; Bilginer Gürbüz B; Ünlüsoy Aksu A; Kasapkara ÇS
    J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1092-1099. PubMed ID: 37791580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.
    Li AM; Thyagu S; Maze D; Schreiber R; Sirrs S; Stockler-Ipsiroglu S; Sutherland H; Vercauteren S; Schultz KR
    Pediatr Hematol Oncol; 2018 Feb; 35(1):45-51. PubMed ID: 29652549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b.
    Volz MS; Nassir M; Treese C; von Winterfeld M; Plöckinger U; Epple HJ; Siegmund B
    BMC Gastroenterol; 2015 Apr; 15():45. PubMed ID: 25881301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen storage disease type Ib: infectious complications and measures for prevention.
    Wendel U; Schroten H; Burdach S; Wahn V
    Eur J Pediatr; 1993; 152 Suppl 1():S49-51. PubMed ID: 7686491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
    Dale DC; Bolyard AA; Marrero T; Kelley ML; Makaryan V; Tran E; Leung J; Boxer LA; Kishnani PS; Austin S; Wanner C; Ferrecchia IA; Khalaf D; Maze D; Kurtzberg J; Zeidler C; Welte K; Weinstein DA
    Curr Opin Hematol; 2019 Jan; 26(1):16-21. PubMed ID: 30451720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: The success of empagliflozin therapy for glycogen storage disease type 1b.
    Klinc A; Groselj U; Mlinaric M; Homan M; Markelj G; Mezek Novak A; Sirca Campa A; Sikonja J; Battelino T; Zerjav Tansek M; Drole Torkar A
    Front Endocrinol (Lausanne); 2024; 15():1365700. PubMed ID: 38919482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b.
    Grünert SC; Gautschi M; Baker J; Boyer M; Burlina A; Casswall T; Corpeleijn W; Çıki K; Cotter M; Crushell E; Derks TGJ; Haas D; Kilavuz S; Kingma SDK; Korman SH; Kozek A; de Laet C; Mundy H; Nassogne MC; Quintero V; Rossi A; Spenger J; Spiegel R; Stephenne X; Stojkov D; Tal G; Veiga-da Cunha M; Wortmann SB
    Mol Genet Metab; 2024 Jun; 142(2):108486. PubMed ID: 38733639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
    Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
    Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare complication of inflammatory bowel disease-like colitis from glycogen storage disease type 1b and its surgical management: A case report.
    Lui FC; Lo OS
    World J Clin Cases; 2021 Jun; 9(16):4081-4089. PubMed ID: 34141769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of inflammatory colitis with pegfilgrastim treatment in a case of severe congenital neutropenia due to glucose 6 phosphatase catalytic subunit-3 deficiency.
    Kaya Z; Eğritaş O; Albayrak M; Göçün PU; Koçak U; Dalgiç B; Gürsel T
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e316-8. PubMed ID: 24322501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myelogenous leukemia and glycogen storage disease 1b.
    Pinsk M; Burzynski J; Yhap M; Fraser RB; Cummings B; Ste-Marie M
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):756-8. PubMed ID: 12468919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report.
    Rossi A; Miele E; Fecarotta S; Veiga-da-Cunha M; Martinelli M; Mollica C; D'Armiento M; Mozzillo E; Strisciuglio P; Derks TGJ; Staiano A; Parenti G
    Ital J Pediatr; 2021 Jul; 47(1):149. PubMed ID: 34215305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory bowel disease in glycogen storage disease type 1B.
    Sanderson IR; Bisset WM; Milla PJ; Leonard JV
    J Inherit Metab Dis; 1991; 14(5):771-6. PubMed ID: 1779622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib.
    Sarajlija A; Djordjevic M; Kecman B; Skakic A; Pavlovic S; Pasic S; Stojiljkovic M
    Eur J Med Genet; 2020 Mar; 63(3):103767. PubMed ID: 31536830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LONG TERM MANAGEMENT OF GLYCOGEN STORAGE DISEASE TYPE 1B: A BRAZILIAN TERTIARY CENTER EXPERIENCE.
    Takao MMV; Sandy NS; Riccetto AGL; Tommaso AMA
    Arq Gastroenterol; 2021; 58(1):87-92. PubMed ID: 33909803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.